As a generally held principle, mere investment or ownership interest in a company does not expose the investor to liability for acts undertaken by the company. However, that principle is being called into question in the context of private equity firms investing in healthcare companies. In two recent cases, healthcare companies along with their sole or majority private equity firm owners settled False Claims Act (“FCA”) cases. These cases illustrate the risk that private equity investors in the healthcare space may face under the FCA, particularly to the extent that they actively manage their portfolio companies.
Trending
- Lessons from Sam Holliday, CEO and Co-Founder of Oshi Health, on Building a Virtual GI Center of Excellence (Pear Healthcare Playbook)
- UnitedHealth Adopts Aggressive Approach to Recover Ransomware Attack Loans (The HIPAA Journal)
- Cardinal Health’s acquisition of GI Alliance: What is means for the industry (Becker’s GI & Endoscopy)
- Why SIBO is often misdiagnosed as IBS [PODCAST] (KevinMD)
- Pfizer to discontinue its GLP-1 pill for obesity due to liver toxicity (STAT)
- The AI Paradigm: A Doctor’s Perspective (The Second Opinion)
- Lilly’s oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial (PRNewswire)
- Gas-sensing capsule takes another big step from lab to commercialization (EurekAlert!)